Lawrence G. Hamel

2019

In 2019, Lawrence G. Hamel earned a total compensation of $776K as Former Chief Development Officer at AcelRx Pharmaceuticals, a 13% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$105,760
Option Awards$181,758
Salary$351,800
Stock Awards$125,500
Other$11,200
Total$776,018

Hamel received $351.8K in salary, accounting for 45% of the total pay in 2019.

Hamel also received $105.8K in non-equity incentive plan, $181.8K in option awards, $125.5K in stock awards and $11.2K in other compensation.

Rankings

In 2019, Lawrence G. Hamel's compensation ranked 10,349th out of 13,971 executives tracked by ExecPay. In other words, Hamel earned more than 25.9% of executives.

ClassificationRankingPercentile
All
10,349
out of 13,971
26th
Division
Manufacturing
4,190
out of 5,701
27th
Major group
Chemicals And Allied Products
1,612
out of 2,200
27th
Industry group
Drugs
1,381
out of 1,886
27th
Industry
Pharmaceutical Preparations
1,027
out of 1,398
27th

Pay ratio

Lawrence G. Hamel's Pay$776,018
Median Employee's Pay$206,159
Pay Ratio

4

to 1

In 2019, the annual total compensation of Lawrence G. Hamel was $776,018.

The annual total compensation of the median employee at AcelRx Pharmaceuticals was $206,159.

The ratio of Lawrence G. Hamel's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 24, 2020.

Hamel's colleagues

We found four more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2019.

2019

Vincent Angotti

AcelRx Pharmaceuticals

Chief Executive Officer

2019

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2019

Raffi Asadorian

AcelRx Pharmaceuticals

Chief Financial Officer

2019

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

News

You may also like